Drug Pipeline

Diroximel Fumarate Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-29 NCT07275515
DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE…		 date change Primary completion pushed: 2029-04 -> 2029-05
2026-05-29 NCT07275515
DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE…		 date change Completion pushed: 2029-04 -> 2029-05
Active Studies by Phase
Phase 3
1
Phase 2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07483632 A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF)… Relapsing Forms of Multiple Sclerosis Not Yet Recruiting
Phase 2
NCT07275515 DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE… Stroke Recruiting
Not specified
NCT06957808 Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia Schizophrenia Disorders Recruiting
NCT05688436 A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants… Multiple Sclerosis Active, Not Recruiting
Sponsors Running Diroximel Fumarate Trials
Biogen (2) King's College London (1) University Hospital, Lille (1)
Disease Areas
Multiple Sclerosis (2) Schizophrenia (1) Stroke (1)
Get alerts when Diroximel Fumarate trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free